SavedAdd your journal

Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2021 / Cilt: 31 - Sayı: 3

Posterior Reversible Encephalopathy Syndrome During Acute Lymphoblastic Leukemia Treatment

Akut Lenfoblastik Lösemi Tedavisi Sırasında Posterior Reversible Ensefalopati Sendromu Gelişen Olgularımız

Cenk ERARSLAN
Eda ATASEVEN
Mehmet KANTAR
Sıla ATAMYILDIZ
Pages
416–420
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we present two cases of ALL who developed PRES during their induction therapy and a literature review of PRES.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological syndrome, characterized by acute onset of headache, altered mental status, visual impairment, nausea, vomiting, seizure, and hypertension.
📊
Key Findings & Data:PRES is a reversible condition if it is recognized early, but neurological damage or even death may occur.
💡
Conclusion & Impact:Herein, we present two cases of ALL who developed PRES during their induction therapy and a literature review of PRES.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological syndrome, characterized by acute onset of headache, altered mental status, visual impairment, nausea, vomiting, seizure, and hypertension. PRES is a reversible condition if it is recognized early, but neurological damage or even death may occur. Herein, we present two cases of ALL who developed PRES during their induction therapy and a literature review of PRES.

Özet

Posterior reversible ensefalopati sendromu (PRES), akut başlangıçlı baş ağrısı, mental durum bozukluğu, görme bozukluğu, bulantı, kusma, nöbet ve hipertansiyon ile karakterize klinik ve radyolojik olarak tanımlanmış bir send- romdur. PRES erken farkedildiğinde geri dönüşümü olan bir durumdur. Ancak bazı vakalarda kalıcı nörolojik hasara hatta ölüme bile yol açabilir. Burada, ALL indüksiyon tedavisi sırasında PRES gelişen iki olguyu literatür ile beraber değerlendirdik, ALL tedavisi sırasında karşılaşabileceğimiz bu önemli duruma dikkat çekmeyi ve farkındalığı arttır- mayı hedefledik

🔖

Cite This Article

ERARSLAN, C., ATASEVEN, E., KANTAR, M., ATAMYILDIZ, S. (2022). Posterior Reversible Encephalopathy Syndrome During Acute Lymphoblastic Leukemia Treatment. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 31 - Sayı: 3, 416–420. https://ajindex.com/articles/557544

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hinchey J, Chaves C, Appignani B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996
  2. 334(8):494- 500. [CrossRef] 2. Anastasopoulou S, Eriksson MA, Heyman M, et al. Posterior reversible encephalopathy syn-drome in children with acute lymphoblastic leukemia: clinical characteristics, risk factors, course, and outcome of disease. Pediatr Blood Cancer. 2018
  3. 66(5):1-10. [CrossRef] 3. Khan SJ, Arshad AA, Bilal M. Posterior reversible encephalopathy syndrome in pediatric cancer: clinical and radiologic findings. J Glob Oncol. 2017
  4. :1-8. [CrossRef] 4. Nilgun E, Aysenur B, Erol E. A case of ALL developing posterior reversible encephalopathy secondary to hyponatremia. J Pediatr Hematol Oncol. 2017
  5. 39(8):476-8. [CrossRef] 5. Musioł K, Waz S, Boroń M, et al. PRES in the course of hemato- oncological treatment in children. Child’s Nerv Syst. 2018
  6. [CrossRef] 6. Tambasco N, Mastrodicasa E, Salvatori C, et al. Prognostic factors in children with PRES and hematologic diseases. Acta Neurol Scand. 2016
  7. 134(6):474-83. [CrossRef] 7. Zama D, Gasperini P, Berger M, Petris M. A survey on hematology- oncology pediatric AIEOP centres: the challenge of posterior reversible encephalopathy syndrome. Eur J Haematol. 2018
  8. 100(1):75-82. [CrossRef] 8. Chen TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr. 2020
  9. 8(September):1-11. [CrossRef] 9. Thavamani A, Umapathi KK, Puliyel M, Super D, Allareddy V, Ghori A. Epidemiology, comorbidities, and outcomes of posterior reversible encephalopathy syndrome in children in the united states. Pediatr Neurol. 2020
  10. [CrossRef] 10. Hafez HA, Ragab I, Sedky M, et al. Patterns, risk factors and outcome predictors of posterior reversible encephalopathy syndrome in pediatric cancer patients. Leuk Lymphoma. 2020
  11. 62(2):462-8. [CrossRef] 11. Ghali MGZ, Davanzo J, Leo M, Rizk E. Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management. Leuk Lymphoma. 2019
  12. 60(10):2365- 72. [CrossRef] 12. Panis B, Vlaar AMM, Van Well GTJ, et al. Posterior reversible encephalopathy syndrome in paediatric leukaemia. Eur J Paediatr Neurol. 2010
  13. 14(6):539-45. [CrossRef] 13. Raj S, Overby P, Erdfarb A, Ushay HM. Posterior reversible encephalopathy syndrome: In-cidence and associated factors in a pediatric critical care population. Pediatr Neurol. 2013
  14. 49(5):335-9. [CrossRef] 14. Chen TH, Lin WC, Tsen